Real Estate Management & Development

JLL’s latest earnings show steady cash flow and sustainable growth, with a 2.12% price rise and strategic upgrades boosting long‑term returns.

Renalytix’s kidneyintelX.dkd test aligns with the new U.S. Kidney Care National Plan, Medicare‑reimbursed and ready for Quest Diagnostics rollout, boosting early kidney disease detection and potential cost savings.

Acumentis (ACU.AX) trades near its 200‑day SMA with a recent governance update boosting investor confidence – a potential mid‑term rebound for Australia’s niche valuation firm.

Discover why Lodha Developers’ stock is falling and how a recent share issuance may dilute value, putting investors’ confidence at risk.

Jiangsu Dagang Co. Ltd. (002077.SZ) sits at the crossroads of semiconductor packaging, testing, and industrial park growth—positioned to capture rising AI, imaging and biometric demand.

Skyworld Development 5315.KL trades flat at MYR 0.34 amid a 12.8% market cap decline—stable yet cautious; see how its ESG focus and expansion plans may drive future upside.

Five Point Holdings (FPH) posts Q3 earnings: revenue driven by Great Park & Hearthstone, cash >$350m, slight share dip, peer mix.

China Merchants Shekou Industrial Zone: flat 0% trading, CNH 7.55, 9.4bn market cap. See its 3% monthly rise, 200‑day SMA, and role in China’s industrial growth.

Explore Beno’s €6.50 capital raise, light‑industrial focus, and renewable‑energy plans—positioning the stock for growth after its 52‑week low.

Fastator Publ’s recent 1.95% rise masks a steep 32% drop, low liquidity, and vague management claims—investors need deeper disclosure to gauge risk.